NDC 67296-2335-03 - oxybutynin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2335
- Requested NDC
- 67296-2335-03
- Package NDCs from labels
- 67296-2335-3, 67296-2335-03
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| oxybutynin - Redpharm Drug | Redpharm Drug | 2026-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Artificial Tears Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Chain Drug Marketing Association, Inc. | 1f669655-4bc7-0175-e063-6294a90a305a | 2025-12-30 | Warnings | FZ989GH94E |
| Equate Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | Walmart, Inc. | ead9f271-0f15-1fff-e053-2a95a90a93ac | 2025-12-30 | Warnings | FZ989GH94E |
| Eye Love Heyedrate Long Lasting Hydration | GLYCERIN, POVIDONE | Physician Recommended Neutraceuticals, L.P. | f321dea1-3251-eaa8-e053-2995a90aaf95 | 2025-12-30 | Warnings | FZ989GH94E |
| Quality Choice Moisturizing Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Chain Drug Marketing Association, Inc. | 1fb81759-5931-59c8-e063-6294a90a2277 | 2025-12-30 | Warnings | FZ989GH94E |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 3f7dc283-b168-8251-e063-6294a90a45a2 | 2025-12-24 | Warnings, Adverse reactions | 863628 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 3f7da2a3-ca46-d3e8-e063-6294a90abef3 | 2025-12-24 | Warnings, Adverse reactions | 863636 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Chartwell RX, LLC | e464c8dd-5222-4a6b-b7e9-ca608a403c6e | 2025-12-22 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Accord Healthcare, Inc. | 61496a1e-17bf-4f45-a20c-5bb98fe545ee | 2025-12-16 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | AvKARE | 94471401-a516-0fe7-ec9c-447dd2bee972 | 2025-12-16 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Upsher-Smith Laboratories, LLC | 3ee6835a-7a7d-49a9-8460-2f1dd270ead3 | 2025-12-11 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Ajanta Pharma USA Inc. | 95c2a144-ba0d-4011-ae0f-0e0ca876e8a8 | 2025-11-30 | Warnings, Adverse reactions | 863636 863619 863628 L9F3D9RENQ |
| OUHOE Biotin With Hydrolyzed Collagen | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 43138915-5fe1-6e32-e063-6294a90abefa | 2025-11-27 | Warnings | ZF94AP8MEY |
| HOUKEA Pure Magnesium Oil | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 33fc279b-3b15-973d-e063-6394a90aad3e | 2025-11-27 | Warnings | ZF94AP8MEY |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 44990ed6-b8e7-40f5-b636-e848024ec6d8 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 0697b3cf-b146-47c0-b5a5-5905ae8d1c97 | 2025-11-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | VERITYRX, LLC | 427b6ffb-3ff4-932f-e063-6394a90ae8b9 | 2025-10-31 | Warnings, Adverse reactions | L9F3D9RENQ |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.